Intravital imaging emerged as an indispensible tool in biological research, and a variety of imaging techniques have been developed to noninvasively monitor tissues in vivo. However, most of the current techniques lack the resolution to study events at the single-cell level. Although intravital multiphoton microscopy has addressed this limitation, the need for repeated noninvasive access to the same tissue in longitudinal in vivo studies remains largely unmet. We now report on a previously unexplored approach to study immune responses after transplantation of pancreatic islets into the anterior chamber of the mouse eye. This approach enabled (i) longitudinal, noninvasive imaging of transplanted tissues in vivo; (ii) in vivo cytolabeling to assess cellular phenotype and viability in situ; (iii) local intervention by topical application or intraocular injection; and (iv) real-time tracking of infiltrating immune cells in the target tissue. allorejection | in vivo imaging | T-cell dynamics | infiltration | islet grafts R ecent advances in intravital microscopy have enabled visualization and quantification of key biological processes in the physiological context of the natural environment in situ (1) , revealing phenomena not predicted by in vitro studies. This insight has spurred a need for intravital imaging approaches that enable combined noninvasive and longitudinal monitoring of the same target tissue with cellular resolution. Techniques such as magnetic resonance imaging and positron emission tomography or bioluminescence (2) have enabled noninvasive visualization of organs/tissues deep within the body by relying on macroscopic and indirect parameters (3, 4) . However, even with the use of high-contrast materials or tissue-specific luminescence, these techniques cannot achieve single-cell level sensitivity because of high background signals and low spatial resolution (5) . These limitations were addressed with the advent of multiphoton microscopy (6) , that enabled high-resolution intravital imaging. Recently, intravital immunoimaging studies adopting multiphoton microscopy revealed complex dynamic behaviors of immune cells (1) crucial for immune function. Most studies, however, have mainly focused on the immune cell behavior during the priming phase in lymph nodes (7) (8) (9) , and a few studies have addressed the movement of T-effector (T eff ) lymphocytes within solid tumors or autoimmune encephalomyelitis lesions (10) (11) (12) . Very recently, the kinetics of dendritic cells and T eff cells during the phases of cutaneous graft rejection have been described using multiphoton microscopy (13) . Therefore, availability of new analytical tools with increased resolution is furthering the horizons of immunobiology, with the characterization of novel biological phenomena associated with 3D dynamic behavior of immune cells within target tissues during their destruction in vivo, that is improbable to predict based in ex vivo and in vitro assays.
Pancreatic islets have been extensively used in animal models to study immune processes (14) . Islet cells are subject to immune attack during autoimmunity (i.e., type 1 diabetes) and during allorejection after transplantation, making them an ideal experimental model with clinical relevance. In small-animal models, pancreatic islets are commonly transplanted under the kidney capsule. This process has allowed reliable monitoring of graft function and survival noninvasively based on metabolic readouts (e.g., glycemia). However, in vivo imaging of subcapsular islet grafts is cumbersome, as it requires surgical exposure of the kidney precluding the ability to image longitudinally the same islets (15) . Additionally, the imaging resolution is severely compromised by the thick kidney capsule. The need for invasive surgical access to the pancreas also limits the number of repeated sessions to image islet autoimmunity (1, 16) . We have previously demonstrated that individual syngeneic pancreatic islets transplanted into the anterior chamber of the mouse eye can be repeatedly imaged with single-cell resolution (17, 18) . Here, we describe that the intraocular islet transplantation model is well suited to study immune cell responses by live microscopy. This model thus enables high-resolution longitudinal analysis in the same tissue of the dynamic patterns and interactions of immune cells with target cells, and allows in situ cytolabeling and acute modulation of the transplant microenvironment in the living animal.
Results

Longitudinal Imaging of T eff Cell Infiltration and Dynamics in Target
Tissues in Vivo. To study the in vivo kinetics and dynamics of cellular movement and interactions during rejection of allogeneic tissues, we used a model of fully MHC-mismatched pancreatic islet transplantation without immunosuppression to evaluate the natural history of the immune response. DBA/2 (H-2 d ) mouse islets were implanted into the anterior chamber of the eye of immune competent C57BL/6 (H-2 b ) recipients that express GFP in activated and memory T lymphocytes (B6.129P2-Cxcr6tm1Litt/J) (19) ( Fig. 1 A and B) . Similarly to what has been reported in islets transplanted under the kidney capsule (15) , our longitudinal noninvasive in vivo imaging studies in the same islet grafts revealed that the GFP-labeled T-cell infiltrate increased substantially around and within the allografts at postoperative day (POD) +14, and that T-cell infiltration paralleled islet destruction ( Fig. 1C and Fig. S1 ). Furthermore, when adequate numbers of allogeneic islets were transplanted into chemically induced diabetic animals, allograft rejection invariably resulted in loss of graft function (Fig. 1D ). No infiltration was seen in control syngeneic islets which were intact during the follow up and never lost function ( Fig. 1 A-D) . These results demonstrate that allorejection of pancreatic islets occurs in the anterior chamber of the eye despite the notion of being an immune privileged site (20, 21) . This finding was further confirmed by typical priming and lymphocyte activation in associated lymph nodes (axillary and cervical) and spleens of intraocular allograft recipients ( Fig. 1E ), even though rejection of intraocular islet grafts appeared to be delayed compared with those under the kidney capsule.
We next examined the movement of infiltrating GFP-labeled T lymphocytes in 3D time-lapse recordings lasting 20 min (4D imaging) ( Fig. 1 F and G, and Movie S1). The recordings were acquired in the same islet grafts at different time points noninvasively (Movie S2). Because islet rejection was not a synchronous phenomenon, we used the day on which the volume of individual islets was reduced by ≥30% as rejection onset (rejection time 0 ± 1 d), which we termed "acute phase" of rejection. Quantitative tracking of GFP-labeled T cells within the islets revealed significant changes in T-cell movement during acute rejection compared with ≥3 d before rejection ( Fig. 1H and Fig. S1F ). Taken together, these results demonstrate that intraocular transplantation enables longitudinal in vivo imaging with single-cell resolution of immunological events within target tissues noninvasively.
Fluorescence Labeling of Target and Immune Cells in Vivo. We injected fluorescence-labeled antibodies directly into the anterior chamber of the eye at different time points after transplantation to assess the phenotype of the graft-infiltrating GFP-labeled immune cells in vivo (22) . The majority of the antibody-labeled GFP + T cells within allogeneic grafts was CD8 + (≥80%) and few were CD4 + (<10%) ( Fig. 2A and Movie S3). Most GFP-labeled CD8 + T-cells expressed CD25 and none were positive for L-selectin (CD62L), confirming their activated status. These cells also expressed lymphocyte function-associated antigen-1 (LFA-1), which is essential for leukocyte extravasation upon activation (23) ( Fig. S2A ). Control isotype antibodies confirmed specific labeling. Flow cytometry analysis of GFP-labeled lymphocytes in lymph nodes derived from intraocular islet allograft recipients showed similar proportions of CD8 + and CD4 + T-cells (78.2 ± 1.2% and 12.3 ± 1.2%, respectively) ( Fig. S2B ).
We also labeled intraocular target islet cells with early (annexin V) and late (DAPI) apoptotic markers. In vivo 4D imaging during acute rejection showed close association of "ruffled" GFP-labeled T cells with annexin and DAPI-labeled islet cells ( Fig. 2B and Movie S4). Approximately 70% of the graft-infiltrating GFP-labeled T cells contacted apoptotic islet cells. Given the focal destruction of the islets near clusters of GFP-labeled T-cells, we further assessed these cells for effector function (Fig. 2C) . In vivo dynamic studies showed the presence of lytic granules (visualized by intraocular Lysotracker injection) within GFP-labeled T cells and showed their polarization toward multiple target islet cells (24) (Movie S5). Examination of frozen sections of intraocular islet grafts demonstrated a similar staining pattern of the intracellular cytolytic enzymes granzyme B and perforin in graft-infiltrating GFP-labeled T cells ( Fig. S2 ), thus confirming our in vivo findings.
Four-dimensional imaging further allowed discerning different morphologies and behaviors of graft-infiltrating T lymphocytes. We consistently identified three phenotypes: round, elongated, and ruffled cells ( Fig. 2E and Movie S6). Round cells were stationary and commonly found surrounding the allografts early after transplantation, whereas elongated cells traveled long distances with a mean instantaneous velocity of ∼3.5 μm/min. Ruffled cells, however, formed clusters within the islets and exhibited a complex dynamic behavior ( Fig. S2 and Movie S7). Interestingly, both fraction and number of ruffled cells increased significantly during acute rejection ( Fig. 2F ). Similar clustering of T cells was also observed under the kidney capsule by invasive in vivo imaging performed in a single session during acute rejection ( Fig. 2D ). These results highlight the utility of our approach in assessing cellular phenotypes and viability in longitudinal noninvasive in vivo imaging studies.
Direct Pharmacological Manipulation of T eff Cells in Graft Tissue in
Vivo. Local pharmacological intervention in target tissue is difficult in vivo. However, ophthalmologists routinely inject substances into the anterior chamber of the eye for diagnostic or therapeutic purposes without producing systemic effects. We injected TAK-779, a specific antagonist of the chemokine receptors CCR5 and CXCR3 (25, 26) , directly into the anterior chamber of the eye. Within 10 min of TAK-779 treatment, we observed significant phenotypic and dynamic changes in the individual graft-infiltrating GFP-labeled T cells ( Fig. 3A and Movie S8). We tracked single cells and found that the majority of the T cells converted from a highly dynamic to a round, stationary phenotype after TAK-779 treatment. Subsequent local administration in the same eye of CXCL9/CXCL10, the natural ligands to CXCR3, reversed the effects of TAK-779 and resulted in significant phenotypic and dynamic changes ( Fig. 3B) .
We also performed studies using systemic, chronic blockade of CCR5/CXCR3 with TAK-779. Longitudinal in vivo imaging in treated animals showed reduced initial infiltration of the islet allografts by T cells followed by similar numbers during onset, albeit delayed, acute rejection compared with untreated animals (Fig. 3C ). However, the relative proportion of the ruffled cells within the grafts was significantly reduced (Fig. S3A ). This treatment also resulted in significantly slower overall T-cell velocity (Fig. 3D) . Importantly, the lower proportion of ruffled cells and the slower movement dynamics associated with slower destruction of the allografts ( Fig. S3B ) and delayed rejection ( Fig. 3E ). Together, these results show a primary role of ruffled T eff cells in allorejection of pancreatic islets. These results also demonstrate that our approach has the spatial and temporal resolution to assess acute and longitudinal effects of interventions within target tissues in the living organism noninvasively.
Discussion
We report on a unique approach that combines transplantation into the anterior chamber of the mouse eye and high-resolution confocal microscopy to enable longitudinal, noninvasive imaging of immune responses within target tissues during allorejection, with unprecedented detail in vivo. This approach also enables in situ fluorescence cytolabeling and local pharmacological intervention by intraocular injection or topical application. To demonstrate the versatility of our approach, we used pancreatic islets as an example because they are subject to immune attack in autoimmune diabetes and during allorejection after transplantation. Typical immune activation was observed in lymphoid organs and destruction of intraocular islets invariably occurred despite the putative "immune privilege" properties of the anterior chamber of the eye. This result is possibly due to the inflammation ("danger") generated with the transplant procedure and to the ability of isolated islets to produce proinflammatory and proangiogenic factors that lead to revascularization of the islet grafts ( Fig. S1E ).
During progression of immune cell-mediated destruction of islet allografts, we examined the morphology and dynamic behavior of T eff cells using longitudinal noninvasive in vivo imaging in the same islet grafts. We found that a ruffled phenotype of CD8 + T eff cells predominated during acute rejection and was likely responsible for the significantly increased net translational movement during this phase. This behavior is likely the result of the polyclonal reaction to alloantigens and to the lack of specific antigen recognition in the context of MHC molecules on target cells, which is required for the formation of central supramolecular clusters and establishment of segregated secretory immunological synapses (27) (28) (29) . Indeed, our results showed lack of CD8 and LFA-1 clustering and no segregation of lytic granules toward contact zones with single targets despite expression of its ligand intercellular adhesion molecule-1 on the islet cells (30, 31) . Although further studies are needed to fully characterize this dynamic behavior and elaborate on its biological significance, it is likely that it favored simultaneous short contacts with multiple target islet cells, promoting surface exploration and antigen sampling, and possibly ensuring efficient and timely target killing during islet allorejection (7, 32, 33) . This theory is further supported by our findings after blockade of the chemokine receptors CCR5 and CXCR3.
Chemokines and their receptors play an essential role in immune cell trafficking. Using our approach, we acutely induced changes in the morphology and dynamic behavior of graft-infiltrating T eff cells by locally modulating the CCR5/CXCR3 signaling pathways. CCR5/CXCR3 and their ligands are upregulated during rejection on infiltrating CD8 + T eff cells and in pancreatic islets, respectively (34) (35) (36) (37) . Following sequential treatments with TAK-779 and CXCL9/CXCL10 in the same eye, individual T cells transitioned between the stationary, round, and the motile, elongated phenotypes. More importantly, chronic CCR5/CXCR3 blockade reduced the ruffled phenotype in the T eff cell infiltrate, slowed their movement dynamics, and was associated with delayed graft rejection.
In summary, our findings demonstrate that transplantation into the anterior chamber of the eye provides a versatile experimental tool that enables longitudinal, noninvasive in vivo imaging of immune responses within target tissues with cellular resolution. This process allows studying cell-cell interactions within target tissues and visualizing cell signaling and motility in situ. Being able to noninvasively monitor the same target tissue and study immune responses longitudinally provides new experimental readouts that can be used in transplantation, cancer, and autoimmune biology. This process also provides a platform for drug screening where continuous monitoring of target tissue can be performed noninvasively in the anterior chamber of the eye after local or systemic intervention in vivo. Future studies combining our approach and humanized mouse models (38, 39) will improve our understanding of immune cell dynamics in human disease and may ultimately yield new therapies.
Materials and Methods
Pancreatic Islet Isolation and Transplantation. Animal procedures were approved by the University of Miami International Animal Care and Use Committee. Murine pancreatic islets were isolated as previously described (40) . Isolated islets were cultured overnight and transplanted into the anterior chamber of the eye or under the kidney capsule, as previously described (17, 18) .
In Vivo Imaging in the Anterior Chamber of the Mouse Eye. As described previously (17, 18) , we imaged the same intraocular islet grafts repeatedly at the indicated time points using 3D single-photon fluorescence confocal microscopy. In 4D recordings, in addition to the isoflurane anesthesia, mice were intraperitoneally injected with 50 μL xylazine (5 mg/mL; AnaSed) ∼10 min before imaging. Islet cells were visualized using reflected laser (backscatter). Blood vessels were visualized by TRITC-dextran (2 × 10 6 M.W.; Invitrogen) injected via the tail vein (0.1 mL of 10 mg/mL solution).
Image Analysis. Z-stacks of 512 × 512 pixels (0.1-0.75 μm per pixel) xy sections with 0.5-to 3-μm z-spacing were acquired using the resonant scanner, built into a Leica SP5 imaging system (17) . Z-stack images were denoised and con-trast-enhanced using Volocity software (Improvision; PerkinElmer). The z-stack thickness was adjusted to span the whole imaged islet. Analysis of islet volume and T-cell counts were performed semiautomatically with Volocity. The islet volume was measured based on a 3D region of interest outlining the whole islet. The T cells inside the region of interest (i.e., islet) were automatically counted by the software based on the GFP fluorescence. In 4D recordings, z-stacks were acquired every 1 to 3 min for 20 min. Time-lapse registration (i.e., drift correction) was done manually with Volocity using static reference points in the reflection channel (namely, islets). Movies were automatically generated from registered 4D recordings. We tracked > 2,000 T lymphocytes in registered time-lapse studies acquired at different time points on the same allogeneic islets. All dynamic parameters were derived based on 3D tracking analysis of 20-min time-lapses, performed on ≥ three islets per time point (± 1 d) .
In Vivo Fluorescence Cytolabeling. Under a stereoscope, the needle of a disposable insulin syringe (31-G Ultra-Fine needle; BD) was inserted into the anterior chamber near the limbus. Great care was taken to avoid contact with the iris and engrafted islets. Once inside the anterior chamber, the solution to label islet cells or T lymphocytes was injected slowly over ∼3 to 5 min. Excess fluid was released periodically through the same entry port to avoid excessive pressure inside the eye. The slow delivery and small needle gauge ensured minimal incision and disturbance. To visualize apoptotic cells, 10 μL of undiluted Alexa 568-conjugated annexin V (Invitrogen) and 20 μL of DAPI (100 μg/mL; Invitrogen) were used. By intentionally damaging the iris with a needle, we confirmed that positive annexin and DAPI stain was exclusive to mechanically injured cells. To allow visualization of endocrine and lytic granules within islet cells and the T lymphocytes, respectively, 300 μL of lysotracker Red DND-99 (5 μM; Invitrogen) were injected while frequently releasing excess volume. A concentration of 5 μM was used based on the assumption that the injected volume is further diluted inside the anterior chamber to a final concentration ≤ 1 μM (41-43). To label different surface markers on T cells, 20 μL of specific antibodies diluted 1:50 in sterile Fcblocking solution (SuperBlock Blocking Buffer; Pierce) were directly injected into the eye as described above. It should be noted that not all infiltrating cells were labeled because of limited antibody penetration into the tissue. Statistical Analysis. For statistical comparisons, we used Student t test (to compare two samples) or one-way ANOVA (to compare multiple samples) followed by multiple comparison procedures with the Holm-Sidak method (SigmaStat; Systat). Survival curves were compared using the log-rank test (Prism; GraphPad) and expressed as median survival time. Data were presented as means ± SD or SE (SEM).
Additional materials and methods are available in SI Materials and Methods.
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Mice. Animal procedures were performed under protocols reviewed and approved by the University of Miami International Animal Care and Use Committee. Mice were purchased from the Jackson Laboratory or bred at our center. Animals were housed in Virus Antibody Free rooms and kept into microisolated cages with free access to autoclaved food and water.
Islet Transplantation into the Anterior Chamber of the Eye. For metabolic studies, recipient mice were rendered diabetic (nonfasting glycemia ≥ 350 mg/dL) with a single intravenous streptozotocin injection (200 mg/kg; Sigma). Two groups of diabetic mice received transplantation into the anterior chamber of one eye of either ∼300 islet equivalents (IEQ) from syngeneic (C57BL/6; n = 10) or ∼600 IEQ from allogeneic (DBA/2; n = 9) donor mice, respectively. Nonfasting glycemic levels were monitored using portable glucometers (OneTouchUltra2; LifeScan) to assess graft function (reversal of diabetes) and rejection. Rejection was confirmed by return to hyperglycemia (defined as nonfasting glycemia > 200 mg/dL for three consecutive days). For imaging studies, C57BL/6 (B6.129P2-Cxcr6 tm1Litt /J; Jackson Laboratories) (1) mice (n ≥ 11) received ∼100 IEQ from DBA/2 donors into one eye. Control C57BL/6 mice (n = 6) received ∼100 IEQ of syngeneic islets. There was no dependency of the time to rejection on the alloantigen load (100 versus 600 islets), as evidenced by similar rejection tempo in metabolic and imaging studies (Fig. 1G ).
Intravital Microscopy of Transplanted Animals. Transplanted animals were anesthetized with an air/isoflurane mixture delivered through a custom-built mask incorporated in a stereotaxic holder (SG-4N; Narishige). The mouse was placed on a heating pad and positioned with the eye containing the engrafted islets facing up. The eyelid was carefully pulled back as described previously (2, 3) . Fluorescence confocal imaging was performed using an upright Leica DMLFSA microscope with long distance water-dipping lens (Leica HXC APO 20× 0.5W), using sterile saline solution as an immersion liquid. A digital image of the transplanted eye was obtained on day 3 after transplantation, and was used as a map to revisit the same islets for longitudinal imaging.
Islet Transplantation Under the Kidney Capsule. Islet transplantation under the kidney capsule was performed in C57BL/6 recipients, as previously described (4) . Briefly, the left kidney was exposed, a breach was done in the capsule at the cranial pole, and a polyethylene catheter containing the islets was inserted into the subcapsular space, the DBA/2 islets released by advancing the plunger of a 1-mL precision syringe (Hamilton). The incision was sealed by electric cautery (Medi-Pak), the kidney replaced in the abdomen, and fascia and abdominal wall sutured. For imaging studies, DBA/2 islets were transplanted into C57BL/6 (B6.129P2-Cxcr6 tm1Litt /J) recipients following the same procedure.
In Vivo Imaging of GFP-Labeled T Lymphocytes Infiltrating Islet
Allografts Under the Kidney Capsule. Allogeneic islets transplanted under the kidney capsule were imaged during rejection (based on glycemia). Recipient C57BL/6 (B6.129P2-Cxcr6 tm1Litt / J) mice were anesthetized as described above. The mouse was placed on a heating pad and positioned with the side of the kidney containing the engrafted islets facing up toward the objective. An incision was carefully made and the grafted kidney was exteriorized and kept pulled up outside the body without impeding blood flow using a pair of forceps fitted with soft Tygon tubing. The exposed kidney was constantly irrigated with sterile saline solution. For 4D recordings, mice were also injected intraperitoneally with xylazine, as described above. In contrast to the anterior chamber, we were not able to visualize the islet cells in the kidney using reflected laser due to strong backscatter from the thick capsular tissue. GFP-labeled T lymphocytes were visualized through the capsule, albeit, laser penetration and GFPfluorescence recovery were limited (Fig. 2C) .
Immunohistochemistry. Transplanted mice with GFP-labeled T lymphocytes (B6.129P2-Cxcr6 tm1Litt /J) were killed by an isoflurane overdose followed by cervical dislocation. Graft-bearing eyes were procured, fixed in 4% paraformaldehyde (1 h), embedded with sucrose (10%, 20%, and 30% in PBS, for 30 min each), and cryopreserved in O.C.T compound (Tissue-Tek) at −80°C. Frozen eyes were cryosectioned (14 μm) perpendicular to the normal of the iris. Eye sections were washed with PBS (3 × 10 min) and incubated in Fc-blocking solution (SuperBlock Blocking Buffer; Pierce) containing 0.1% Triton 100× (1 h). After permeabilization, sections were incubated overnight in guinea pig anti-insulin primary antibody (1:500; DAKO) or rat anti-mouse PE-conjugated antigranzyme B and AlexaFluor 647conjugated anti-perforin antibodies (1:500; eBiosciences). Primary antibody solution was aspirated and goat anti-guinea pig Alexa 568-labeled secondary antibody (1:500; Invitrogen) was added overnight. Finally, DAPI (1:600; Invitrogen) was added for 30 min before washing with PBS (3 × 10 min) and adding mounting solution (Biomedia Corp.) and glass coverslips.
Elispot Assays for T-Cell Production of IL-2 and IFN-γ. Elispot plates (Immunospot M200; Cellular Technologies) were coated with rat anti-mouse IL-2 (1:250) or IFN-γ (1:500) antibodies (BD Pharmingen) and blocked with sterile 1% BSA in PBS. Lymph node (pooled axillary and cervical) or spleen cells (10 6 per well) from B6.129P2-Cxcr6 tm1Litt /J allograft recipient mice were harvested at day 5 (n = 3) and day 6 (n = 3) after transplantation and plated in RPMI-1640 media (Invitrogen) with Mitomycin C (Sigma) treated splenocytes (as stimulators) from DBA/2 mice (0.5 × 10 6 per well) for 24 h. After washing with PBS 0.025% Tween 20, plates were incubated with biotin rat anti-mouse or IFN-γ antibodies (1:250; BD Pharmingen) overnight at 4°C. Alkaline phosphatase-conjugated antibiotin antibody (1:250; Vector Lab) was added for 1.5 h at 20°C and developed with nitroblue tetrazolium chloride (1:250; Bio-Rad) and 5-bromo-4chloro-3-indolyl phosphatase substrate (Sigma). The revealed spots were counted on an Immuno-Spot Series 2 Analyzer (Cellular Technologies). Splenocytes and lymphocytes from nontransplanted mice (B6.129P2-Cxcr6 tm1Litt /J; n = 3) served as controls. Results are reported as a mean of triplicate wells ± SD.
Flow Cytometry Analysis of Lymphocytes and Splenocytes. Spleens and pooled cervical and axillary lymph nodes (ipsi-or contralateral) were harvested from B6.129P2-Cxcr6 tm1Litt /J allograft recipient mice at day 6 (n = 3 mice) after transplantation, as well as from nontransplanted control mice (n = 5), and placed into a sterile Petri dish with a 70-μm nylon cell strainer (BD Biosciences). Cells were collected and treated with TAC lysis buffer (0.017 M Tris, 0.14 M ammonium chloride, pH 7.2) to lyse red blood cells. The pelleted cells were counted and used for Elispot assays (see below) and flow cytometry.
Cell suspensions were incubated with Fc-block rat anti-mouse CD16/CD32 antibody (BD Pharmingen) and then stained with rat anti-mouse CD4-APC and rat anti-mouse CD8-PerCP Cy5.5 antibodies (eBiosciences). After staining, cells were incubated with DAPI to identify nonviable cells. Cell-surface markers on stained cells were analyzed by flow cytometry by gating on the DAPI-negative and GFP-positive cells and collecting ∼50,000 events. Data were acquired on a BD LSRII Special Order System (BD Biosciences) and analyzed using FACS Diva 6.0 analysis software (BD Biosciences). TAK-779 solution was prepared in saline at 1.25 mg/mL and administered either systemically [250 μg daily between postoperative day (POD) +10 and POD +17; intraperitoneally] or directly into the anterior chamber of the eye (50 μM; 15-20 μL per injection). The mix of CXCL9 (100 nM; R&D Systems) and CXCL10 (100 nM; Biosource) was prepared in PBS. For direct injection into the anterior chamber of the eye of anesthetized mice, TAK-779 or mixed CXCL9 and CXCL10 solutions were loaded into separate Tygon tubing connected to 500-μL Hamilton syringes with screw-driven plungers. Glass micropipettes (∼30-μm tip diameter) were back-filled after connecting to the tubing and mounted onto separate xyz micromanipulators (Narishige). Injection through the cornea was done slowly to minimize turbulence. Islets were deemed rejected after ≥ 30% reduction in initial islet volume because no more than 13% (i.e., mean + SD) decrease in the volume of syngeneic islet grafts was observed. (E) Longitudinal imaging of the same islet (outlined) revealed incipient revascularization (red) at 5 d after transplantation. Initially, the majority of infiltrating GFP-labeled T lymphocytes (green) appeared near iris blood vessels outside the islet (days 5 and 10). As vessels grew further within the islet, intraislet T-cells appeared near newly formed vessels (day 17). Blood vessels were visualized by intravenous injection of TRITC-labeled dextran (2 × 10 6 D). (Scale bar, 100 μm.) (F) Longitudinal dynamic analysis of displacement (traveled distance in straight line) and path length (cumulative traveled distance) during progression of islet allorejection. Both parameters increased significantly at onset of acute rejection (day 0) compared with ≤ day −3 (shown as means ± SEM; *P < 0.05). ) (E) Instantaneous velocity and 3D shape index (surface area/volume) of ruffled T-cells within allograft (POD +12) are significantly different from those of round and elongated cells. The higher 3D shape index is likely to be due to the complex dynamic behavior of ruffled cells as they engage in simultaneous contacts with neighboring T cells and target islet cells. Data presented as means ± SEM (results based on 161 images of 18 round T cells, 203 images of 27 elongated cells, and 896 images of 32 ruffled cells; *P < 0.05). (F) As a measure of randomness and confinement in cellular motility, despite increased translational movement during acute rejection, we plotted the mean displacement or chemotactic index (displacement/path length) vs. time (1) . This showed increased confinement and random migration by ruffled T cells compared with elongated ones (n = 137 ruffled and 26 elongated cells). Based on our results during acute rejection, the mean velocity of graft-infiltrating T lymphocytes (with > 60% being ruffled; see Fig. 2F ) was ∼30% of that in the lymph node (1, 2) . Assuming a similar reduction in the motility coefficient within the islet allografts compared with the lymph node (3), a value of ∼20 μm 2 /min is expected; we calculated however an average value of ∼8 μm 2 /min, which further supported increased confinement in the movement of the predominating ruffled T-cells within allografts during rejection.
Movie S6. Three-dimensional renderings of the round, elongated, and ruffled T-cell phenotypes shown in Fig. 2 . The movie demonstrates the spherical shape of round cells and the typical elongated shape of fast-moving cells with a characteristic large leading edge and a thin, long europod. It also shows a cluster of ruffled T-cells displaying irregular shapes characterized by long cytoplasmic processes extended in multiple directions.
Movie S6
Movie S7. Three-dimensional rendering of the snapshots shown in Fig. S2D . The movie highlights a cluster of ruffled T-cells in an area where islet tissue was rejected and shows the complex dynamic behavior of the cells.
Movie S7
Movie S8. Sequential recordings (10-min each) in the same intraocular islet allograft (POD +22) before and after intraocular injection of TAK-779 or a CXCL9/ CXCL10 mix. Fluorescence confocal images are shown as maximum projections in intensity scale to illustrate phenotypic changes in the graft-infiltrating GFPlabeled T lymphocytes. Notice the change in the cellular morphology and motility near and within the graft (outlined) after TAK-779 or CXCL9/CXCL10 administration. With TAK-779 treatment, the cells converted to the stationary, round phenotype which was evidenced by the reduced intensity (blue) within their notably shorter lamellipodia around the bright (red) cell bodies. Such changes were reversed with subsequent administration of CXCL9/CXCL10. Recordings were acquired ∼10 min after each treatment; during which time, additional cells migrated into the imaged field. This finding was especially evident after CXCL9/CXCL10 treatment increased movement which associated with significantly increased cellular motility (Fig. 3B ). (Scale bars, 10 μm.)
Movie S8
